Wk 8 Alzheimer and Depression Flashcards
cognition measured in Alzheimer Disease (AD) by…
Mini-Mental State Exam
neuronal changes seen in AD
reduced acetylcholine and acetylcholinesterase
AD pharmacotherapy
raise comical acetylcholine levels and dec glutamate-mediated neuronal cell death
main goals of AD therapy
minimize behavioral disturbances and improve symptoms
acetycholinesterase inhibitors
most effective for tx’ing AD (1st line)
typically result in small improvement in sx’s
most studies involve mild-mod sx’s
may red behavioral disturbances (aggression
may improve cog and behavior
if SE develop, a switch can be initiated 24 hrs after discont of 1st med
adverse effects of AchEl’s
related to inc Ach: depression, headache, anxiety, dizziness, stomach pain, bradycardia (underreported!!), syncope and insomnia
minimized with slow dose titration
GI tract effects of AcheEI’s
N/V (MC symptom all together), diarrhea, dehydration, dec appetite, weight loss and stomach ulcers
Donepazil
first agent approved for mod-severe AD
Galantamine
stimulates at a non-act site (allosteric modulation)
conversion to galantamine
if poor tolerability with donepezil or rivastigmine: wait until SE subside or allow a day washout period prior to galantamine
conversion to galantamine…
no intolerance to donepezil or rivastigmine: begin galantamine the day after stopping donepezil or rivastigmine
high dose PO rivastigmine to patch (Exelon)
> 6 mg/day oral
switch directly to 9.5 mg/24 hr
lower dose PO rivastigmine to patch
<6 mg/day oral
start on 4.6 mg/24 h
switching from donepezil or galantamine to patch
start on 4.6 mg/24 hr
Exelon patch
may cause allergic contact dermatitis dont reuse same site for 14 days recommended sites: upper/lower back alternate sites: chest/upper arms immediate therapeutic
Rivastigmine
oral dose is NOT immediately therapeutic (titrate to each new dose)
“pseudoirreversible”
inhibits G1 AChE > G4 AChE
results in fewer drug-drug interactions
Mementine
after 5 mg BID go to 10 mg q am and 5 mg q pm, then finally 10 mg BID
Depression NT affected
norepinephrine, serotonin (5-hydrozytryptoamine) and dopamine